Preparing Brick and Mortar for a Great Reopening: Spieckerman Speaks Retail

 

As retailers attempt to pull the trigger on reopening brick and mortar in a big way, they know they have to get it right the first time. Yet so much confusion surrounds what is even possible as the corona crisis plays out. Restoring consumer confidence will require clear answers, actionable best practices, and herculean effort. As CEO of facilities management leader, ServiceChannel, Tom Buiocchi is in the business of making that happen for over 500 name brands across 350,000-plus locations. In this Spieckerman Speaks Retail episode, Carol and Tom discuss what it will really take to get brick and mortar retail rolling once again.

In this interview, you’ll learn:

  1. How data will drive retailers’ restart plans
  2. Why retail formats and fixtures will never be the same in the wake of COVID-19
  3. Which compliance tracking tools will emerge as high touch becomes high stakes
  4. Why phased approaches are essential for being reopening-ready

Guest contact information:
Tom Buiocchi email tomb@servicechannel.com
LinkedIn profile https://www.linkedin.com/in/tombuiocchi/
Website www.servicechannel.com

Resources discussed in the episode
Webinar: www.servicechannel.com/reopening

Listen to Previous Episodes of Spieckerman Speaks Retail!

Follow us on social media for the latest updates in B2B!

Latest

NRF 2022 Retail's Big Show
What’s in the Shopping Cart for the 2022 National Retail Federation’s Big Show?
January 14, 2022
 In just a few short days, from January 16th through the 18th, the National Retail Federation will launch Retail’s Big Show in the shopping capital of the world, New York City. As retail Read more
Schools Struggle to Reach Their Education Technology Goals. Here’s Why and How To Fix It.
January 14, 2022
As we hit the two-year mark of the COVID-19 pandemic, the education sector continues to struggle in adjusting to virtual and hybrid education at scale. In 2020, McKinsey estimated that, due to COVID Read more
85% of Clinical Drug Trials Face Delays. What's the True Cost?
85% of Clinical Drug Trials Face Delays. What’s the True Cost?
January 14, 2022
  Clinical trials can save lives and provide new ways to treat disease. The industry estimates that 85% of all clinical trials face delays due to patient enrollment. Understanding that challenge Read more